A method for the inhibition of high affinity glycine transporters, compounds that inhibit these transporters; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of disease states in which glycine is involved are disclosed.

 
Web www.patentalert.com

< Markers for interventional devices in magnetic resonant image (MRI) systems

< Transient event mapping in the heart

> MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia

> Method of diagnosing the chances of pregnancy and the diagnostic kit for the same

~ 00263